WO2015025331A3 - Drug designing for diabetes mellitus using pentacosanoic acid. - Google Patents
Drug designing for diabetes mellitus using pentacosanoic acid. Download PDFInfo
- Publication number
- WO2015025331A3 WO2015025331A3 PCT/IN2014/000518 IN2014000518W WO2015025331A3 WO 2015025331 A3 WO2015025331 A3 WO 2015025331A3 IN 2014000518 W IN2014000518 W IN 2014000518W WO 2015025331 A3 WO2015025331 A3 WO 2015025331A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- diabetes mellitus
- pentacosanoic acid
- drug designing
- decoction
- drug
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/12—Antidiuretics, e.g. drugs for diabetes insipidus
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Diabetes (AREA)
- Epidemiology (AREA)
- Nutrition Science (AREA)
- Physiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Hematology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Medicines Containing Plant Substances (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
The present invention relates to the drug designing performed for the treatment of Diabetes mellitus Type 1 and 2 using a compound Pentacosanoic acid. It is used for the prevention and management of hyperglycemia, abnormal lipids, obesity, hypertension and atherosclerosis involved with diabetic patients. It may enable the design of therapy that can control, treat, and prevent Diabetes mellitus. It can be formulated in a form consisting of decoction, dried decoction, infusion, tincture, dried extract, capsule, tablet, syrup or the like thereof.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IN3687/CHE/2013 | 2013-08-21 | ||
IN3687CH2013 | 2013-08-21 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2015025331A2 WO2015025331A2 (en) | 2015-02-26 |
WO2015025331A3 true WO2015025331A3 (en) | 2015-07-02 |
Family
ID=52484234
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/IN2014/000518 WO2015025331A2 (en) | 2013-08-21 | 2014-08-08 | Drug designing for diabetes mellitus using pentacosanoic acid. |
Country Status (1)
Country | Link |
---|---|
WO (1) | WO2015025331A2 (en) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN109827920A (en) * | 2018-12-29 | 2019-05-31 | 南京同凯兆业生物技术有限责任公司 | The detection method of reduced sugar in a kind of Penicillium citrinum fermentation liquid |
CN115068461B (en) * | 2022-06-07 | 2023-06-20 | 仲恺农业工程学院 | Application of pentadecanoic acid in preparation of preparation for promoting angiogenesis of sow placenta |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0293001A2 (en) * | 1987-05-29 | 1988-11-30 | Lion Corporation | Method for continuous preparation of highly pure monoglyceride |
-
2014
- 2014-08-08 WO PCT/IN2014/000518 patent/WO2015025331A2/en active Application Filing
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0293001A2 (en) * | 1987-05-29 | 1988-11-30 | Lion Corporation | Method for continuous preparation of highly pure monoglyceride |
Non-Patent Citations (2)
Title |
---|
NESTOR M. CARBALLEIRA ET AL.: "Identification and Total Synthesis of Novel Fatty Acids from the Caribbean Sponge Calyx podatypa", JOURNAL OF NATURAL PRODUCTS, vol. 61, no. 8, 1998, pages 1049 - 1052 * |
NESTOR M. CARBALLEIRA ET AL.: "Two Novel Iso-Branched Octadecenoic Acids from a Micrococcus Species", JOURNAL OF NATURAL PRODUCTS, vol. 63, no. 11, 2000, pages 1573 - 1575 * |
Also Published As
Publication number | Publication date |
---|---|
WO2015025331A2 (en) | 2015-02-26 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MX2013004699A (en) | Pharmaceutical combinations for the treatment of metabolic disorders. | |
WO2012055967A3 (en) | Treating diabetes melitus using insulin injections administered with varying injection intervals | |
WO2011018501A3 (en) | Composition including an unsaponifiable fraction | |
CN105341928A (en) | Health-care food capable of reducing blood sugar | |
JOP20210201A1 (en) | Blood glucose lowering compound | |
GB201318936D0 (en) | Pharmaceutical compostion for controlling blood sugar, blood lipid and body weight | |
WO2015121457A8 (en) | Fgf-8 for use in treating diseases or disorders of energy homeostasis | |
WO2015025331A3 (en) | Drug designing for diabetes mellitus using pentacosanoic acid. | |
WO2016190566A3 (en) | Pharmaceutical composition or functional health food for preventing and treating metabolic diseases, containing water extract of pleurotus eryngii var. ferulae (pf.) as active ingredient | |
WO2011052935A3 (en) | Composition for lowering blood sugar, comprising extract of smilax chine l., momordica charantia and cordyceps militaris as active ingredient | |
WO2012019435A3 (en) | Composition for treating neurodegenerative disease or neuropathological condition | |
WO2014018763A3 (en) | Method of treating type i diabetes using apolipoprotein aiv | |
WO2012138146A3 (en) | Composition containing heat-treated powder or extract of glycine soja as active gradient for prevention and treatment of diabetes mellitus and diabetic complications | |
WO2014066400A3 (en) | Methods for the effective treatment of metastatic cancer | |
WO2012141615A3 (en) | Medicament | |
WO2010148533A8 (en) | A pharmaceutical composition with the effect of treating diabetes | |
NZ708511A (en) | Methods for controlling blood pressure and reducing dyspnea in heart failure | |
WO2017220051A3 (en) | Benserazide hydrochloride pharmaceutical composition and medical use thereof for lowering blood sugar | |
WO2013188876A3 (en) | Methods for modulating kallikrein (klkb1) expression | |
EP2684566A4 (en) | Pharmaceutical composition for preventing and treating complications of diabetes containing a traditional oriental medicine extract or a fraction thereof as an active ingredient | |
WO2014185641A3 (en) | Method for preparing health food supplement containing aster scaber | |
CN104922490A (en) | Traditional Chinese medicine special for treating gastrorrhagia | |
WO2014155268A3 (en) | Fgf-r tyrosine kinase activity inhibitors - use in diseases associated with lack of or reduced snf5 activity | |
CN104173648A (en) | Traditional Chinese medicinal composition for treating teniasis | |
Kishimoto | Nausea and loss of appetite: case report |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 14837377 Country of ref document: EP Kind code of ref document: A2 |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
122 | Ep: pct application non-entry in european phase |
Ref document number: 14837377 Country of ref document: EP Kind code of ref document: A2 |